1. Cell Cycle/DNA Damage Epigenetics Apoptosis
  2. HDAC CDK Apoptosis
  3. HDAC1/2 and CDK2-IN-1

HDAC1/2 and CDK2-IN-1 (compound 14d) 是一种有效的 HDAC1HDAC2CDK2 抑制剂,IC50 分别为 70.7,23.1 和 0.80 μM。HDAC1/2 and CDK2-IN-1 可阻断细胞周期,诱导细胞凋亡 (apoptosis)。HDAC1/2 and CDK2-IN-1 表现出良好的体内抗肿瘤活性。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

HDAC1/2 and CDK2-IN-1 Chemical Structure

HDAC1/2 and CDK2-IN-1 Chemical Structure

CAS No. : 2418559-01-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

注册 MCE会员完成审核
即刻享有 积分商城 300 专属积分

Top Publications Citing Use of Products
  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

HDAC1/2 and CDK2-IN-1 (compound 14d) is a potent HDAC1, HDAC2 and CDK2 dual inhibitor, with IC50 values of 70.7, 23.1 and 0.80 μM, respectively. HDAC1/2 and CDK2-IN-1 can block the cell cycle and induce apoptosis. HDAC1/2 and CDK2-IN-1 exhibits desirable in vivo antitumor activity[1].

IC50 & Target[1]

HDAC1

70.7 nM (IC50)

HDAC2

23.1 nM (IC50)

CDK2

0.80 nM (IC50)

体外研究
(In Vitro)

HDAC1/2 and CDK2-IN-1 (compound 14d) shows excellent antiproliferative activities against H460, A375, HepG2, HCT116 and Hela cells with IC50 values of 1.59, 0.47, 0.86, 0.58 and 1.05 μM, respectively[1].
HDAC1/2 and CDK2-IN-1 (0.5 μM, 48 h) significantly inhibits the migration of H460 and A375 cells[1].
HDAC1/2 and CDK2-IN-1 (0-2 μM, 24 h) significantly blocks the cell cycle in the G2/M phase[1].
HDAC1/2 and CDK2-IN-1 (0-2 μM, 48 h) promotes cancer cell apoptosis in a dose-dependent manner[1].
HDAC1/2 and CDK2-IN-1 (1 μM, 12 h) inhibits CDK2 and HDAC activity, causing cancer cell death[1].
HDAC1/2 and CDK2-IN-1 (1 μM, 24 h) strongly increases ROS levels in A375 cells, causes cancer cell death by improving intracellular ROS levels[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis

Cell Line: A375, HCT116, H460 and Hela cells[1]
Concentration: 0, 0.5, 1, 2 μM
Incubation Time: 24 h
Result: Significantly blocked the cell cycle, induced a loss of G0/G1 phase cells and an increase of G2/M phase cells, led to an apparent accumulation of cells in G2/M phase at 0.5 μM (A375, the percentage from 13.70 to 57.03%; HCT116, from 27.46 to 76.99%; Hela, from 7.89% to 51.85%).

Apoptosis Analysis

Cell Line: A375, HCT116, H460 and Hela cell lines[1]
Concentration: 0, 0.5, 1, 2 μM
Incubation Time: 48 h
Result: Promoted cancer cell apoptosis in a dose-dependent manner, with the apoptosis rates of 91.99% (A375), 89.60% (HCT116), 59.10% (H460), and 22.36% (Hela) respectively at the concentration of 2 μM.

Immunofluorescence

Cell Line: A375 cells[1]
Concentration: 1 μM
Incubation Time: 12 h
Result: Significantly inhibited CDK2 and increased the acetylation level of histone H3, inhibited CDK2 and HDAC activity, causing cancer cell death.
体内研究
(In Vivo)

HDAC1/2 and CDK2-IN-1 (BALB/c nude mice, 0-100 mg/kg, IP, once daily for 21 days) significantly inhibits the tumor growth[1].
HDAC1/2 and CDK2-IN-1 (compound 14d) (ICR mice; 4 mg/kg, IV; 20 mg/kg, IP) exhibits desirable pharmacokinetic properties[1].
Pharmacokinetic Parameters of HDAC1/2 and CDK2-IN-1 in male ICR mice[1].

Dose (mg/kg) 4 20
Administration IV IP
T1/2 (h) 1.48 2.84
Tmax (h) 2
Cmax (ng/mL) 1360
AUC0-t (ng/mL*h) 2850 7240
MRT0-t (h) 0.563 4.54
CL (mL/(min/kg)) 23.3
F (%) 50.8

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male ICR mice (n = 9)[1]
Dosage: 4 mg/kg (IV), 20 mg/kg (IP)
Administration: IV, IP, once (Pharmacokinetic Analysis)
Result: Exhibited desirable pharmacokinetic properties.
Animal Model: BALB/c nude mice (5-6 weeks, HCT116 xenograft model)[1]
Dosage: 0, 25, 50 and 100 mg/kg
Administration: IP, once daily for 21 days
Result: Significantly inhibited the tumor growth, the tumor growth inhibitions were 28%, 40% and 44% at doses of 25, 50 and 100 mg/kg, respectively.
分子量

483.95

Formula

C26H22ClN7O

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献

HDAC1/2 and CDK2-IN-1 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
HDAC1/2 and CDK2-IN-1
目录号:
HY-143497
需求量: